Back to Oncology
Oncologyv2005Evidence-Based

Mekhail Extension of the Motzer Score

Predicts survival of metastatic renal cell carcinoma, more accurately than the original Motzer Score by incorporating additional prognostic factors

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
mekhail score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Mekhail Extension of the Motzer Score is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = Sum of present risk factors (each factor = 1 point if present)

Clinical Pearls & Practice Notes

  • More of a historical prognostic tool than a current clinical predictor
  • Best used for selecting patients for clinical trials
  • Not validated for individual survival prediction in modern targeted therapy era
  • The original Motzer score includes only the first 4 factors; Mekhail extension adds prior radiotherapy and number of metastatic sites

Evidence & Literature Citations

  1. Mekhail TM, Abou-Jawde RM, Boumerhi G, Malhi S, Wood L, Elson P, et al. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol. 2005 Feb 1;23(4):832-41. doi: 10.1200/JCO.2005.05.179.
  2. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999 Aug;17(8):2530-40. doi: 10.1200/JCO.1999.17.8.2530.

Score Interpretation Ranges

Favorable Risk0 – 1 pts

0-1 risk factors

Intermediate Risk2 – 2 pts

2 risk factors

Poor Risk3 – 6 pts

≥3 risk factors

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.